Biddick Allison A, Bacek Lenore M, Fan Shirley, Kuo Kendon W
Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, Auburn, AL.
Statistical Consulting Center, College of Mathematics and Statistics, Auburn University, Auburn, AL.
J Vet Emerg Crit Care (San Antonio). 2020 Mar;30(2):179-186. doi: 10.1111/vec.12933. Epub 2020 Feb 25.
To determine whether a normal cardiac troponin I (cTnI) concentration and normal ECG on entry rule out the development of a clinically significant cardiac arrhythmia (CSCA, defined as an arrhythmia requiring anti-arrhythmic treatment) in dogs that have sustained blunt trauma.
Prospective, observational study. Client-owned dogs were enrolled between January 2015 and November 2016.
University teaching hospital.
Forty-seven client-owned dogs with a history of witnessed or suspected blunt trauma within 24 hours prior to presentation to the hospital.
On admission to the emergency service, dogs had a standard 3-lead ECG and cTnI concentration (using a veterinary point-of-care device ) performed. Animal Trauma Triage (ATT) scores, Modified Glasgow Coma Scale (MGCS), and the details regarding the nature and timing of the injury were recorded. The patients were monitored in the ICU for a minimum of 24 hours on continuous ECG telemetry. Cardiac rhythm was monitored every hour, and any abnormalities were noted. The need for anti-arrhythmic therapy was recorded. There were no treatment interventions.
Five of 47 dogs (10.6%) developed a CSCA during hospitalization after sustaining blunt trauma. A normal entry ECG and normal cardiac troponin concentration on entry had a 100% negative predictive value (NPV) for ruling out the development of a CSCA, although a normal cardiac troponin concentration alone also had an NPV of 100%. A normal entry ECG had an NPV of 95.3%. The prognosis for survival to discharge was 89.4% in this study population (42/47 dogs).
In dogs with blunt trauma, an entry cTnI concentration or a combination of cTnI and ECG on entry may be useful in determining which patients are at a higher risk for the development of CSCA during the first 12 to 24 hours after the trauma.
确定钝性创伤犬入院时心肌肌钙蛋白I(cTnI)浓度正常且心电图正常是否可排除临床上显著的心律失常(CSCA,定义为需要抗心律失常治疗的心律失常)的发生。
前瞻性观察性研究。2015年1月至2016年11月纳入客户拥有的犬只。
大学教学医院。
47只客户拥有的犬只,在入院前24小时内有目击或疑似钝性创伤史。
犬只进入急诊室时,进行标准的三导联心电图检查和cTnI浓度检测(使用兽医即时检测设备)。记录动物创伤分诊(ATT)评分、改良格拉斯哥昏迷量表(MGCS)以及损伤的性质和时间细节。患者在重症监护病房通过连续心电图遥测至少监测24小时。每小时监测心律,记录任何异常情况。记录抗心律失常治疗的需求。未进行治疗干预。
47只犬中有5只(10.6%)在钝性创伤后住院期间发生了CSCA。入院时心电图正常且心肌肌钙蛋白浓度正常对排除CSCA的发生具有100%的阴性预测值(NPV),尽管仅心肌肌钙蛋白浓度正常的NPV也为100%。入院时心电图正常的NPV为95.3%。本研究人群(47只犬中的42只)出院存活的预后为89.4%。
在钝性创伤犬中,入院时的cTnI浓度或cTnI与心电图的联合检测可能有助于确定哪些患者在创伤后12至24小时内发生CSCA的风险较高。